Structural insights into substrate and inhibitor binding sites in human indoleamine 2,3-dioxygenase 1
Human indoleamine 2,3-dioxygenase 1 (hIDO1) is an immunotherapeutic target for cancer therapy. Here, the authors present the substrate-, inhibitor- and effector-bound hIDO1 crystal structures, which give insights into the mechanism and reveal a second small molecule binding site, which is of interes...
Enregistré dans:
Auteurs principaux: | Ariel Lewis-Ballester, Khoa N. Pham, Dipanwita Batabyal, Shay Karkashon, Jeffrey B. Bonanno, Thomas L. Poulos, Syun-Ru Yeh |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f8b733a4df2546f48fc72aa65deeac3d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Indoleamine-2,3-Dioxygenase as a Perioperative Marker of the Immune System
par: Corina Bello, et autres
Publié: (2021) -
Natural CD4+ T-cell responses against indoleamine 2,3-dioxygenase.
par: Shamaila Munir, et autres
Publié: (2012) -
Emerging Roles on Immunological Effect of Indoleamine 2,3-Dioxygenase in Liver Injuries
par: Lingyan Xu, et autres
Publié: (2021) -
TRYPTOPHAN AND INDOLEAMINE-2,3-DIOXYGENASE (IDO) IN PATHOGENESIS OF IMMUNOSUPPRESSIVE CLINICAL CONDITIONS
par: V. A. Kozlov, et autres
Publié: (2017) -
Regulation of indoleamine 2,3-dioxygenase in primary human saphenous vein endothelial cells
par: Mouratidis PX, et autres
Publié: (2015)